Mental Health Clinics in Rehrersburg, PA Accepting Medicare
2 Mental Health Clinics found. Showing 1 - 2
 Ascend Clinical Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 33 Teen Challenge Rd, Rehrersburg, PA 19550 Phone: 717-933-4181 Fax: 717-754-0617 |
Ascend Ministries Withdrawal Management Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 33 Teen Challenge Rd, Rehrersburg, PA 19550 Phone: 717-933-4181 |
News Archive
Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study
Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.
Post-Soviet economic breakdown may have contributed to re-emergence of NTDs in Central Asia
According to an article by Peter Hotez, president of the Sabin Vaccine Institute, and Ken Alibek of Nazarbayev University in Astana, Kazakhstan, published Tuesday in the journal PLoS Neglected Tropical Diseases, Central Asia "continues to suffer from a post-Soviet economic breakdown that may have contributed to a re-emergence of several NTDs in the area, especially among its most economically disadvantaged groups," a PLoS press release states.
CBC, Scarab Genomics form agreement to increase manufacturing yield of Solinex rhu-pGSN
Critical Biologics Corporation (CBC) and Scarab Genomics announced today a strategic agreement to substantially increase the manufacturing yield of CBC's lead therapeutic protein candidate, Solinex™, an intravenous formulation of recombinant human plasma gelsolin (rhu-pGSN).
Top-line results from Merck's vorapaxar clinical study on thrombosis
Merck, known outside the United States and Canada as MSD, today announced the top-line results of the TRA-2P (Thrombin Receptor Antagonist in Secondary Prevention of atherothrombotic ischemic events) study of vorapaxar.
Trinean launches DropSense96 and DropPlate 16 G for genomic DNA quantification
Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.
› Verified 1 days ago